ARK Diagnostics, Inc is a company that develops and commercializes in vitro diagnostic immunoassays for detecting and managing drug levels
ARK Diagnostics, Inc. is committed to improving health care through the design, development, manufacture and distribution of in vitro diagnostic (IVD) immunoassays for therapeutic drug monitoring (TDM), urine drug testing (UDT) and other small molecules. Our focus is the production of high quality, convenient, cost-effective products for routine use in research and clinical practice.
Johnny Valdez, President/CEO
ARK Diagnostics, Inc. provides reliable products and customer service. By listening and working with customers to find effective solutions for their needs, ARK strives to deliver consistent customer satisfaction.
ARK Diagnostics, Inc. is committed to complying with all applicable regulatory requirements in the countries where its products are offered and shall maintain the effectiveness of its quality management system for the design, development, manufacture and distribution of in vitro diagnostic medical devices.
The President and CEO of ARK Diagnostics, Inc. leads the management team and is responsible for the ARK Quality Management System. Each ARK Diagnostics, Inc. employee is empowered to be responsible for compliance to this policy.